Cathie Wood Compugen LTD Transaction History

Ark Investment Management LLC

$10.5 Billion
Q3 2024

A detailed history of Cathie Wood (Ark Investment Management LLC) transactions in Compugen LTD stock. As of the latest transaction made, Ark Investment Management LLC holds 1,092,183 shares of CGEN stock, worth $1.79 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,092,183

Previous 1,088,271 0.36%

Holding current value

$1.79 Million

Previous $1.83 Million 8.1%

% of portfolio

0.02%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$1.56 - $2.1 $6,102 - $8,215	3,912 Added 0.36%	1,092,183 $1.98 Million
Q2 2024 Jul 26, 2024	BUY	$1.68 - $2.52 $82,284 - $123,427	48,979 Added 4.71%	1,088,271 $1.83 Million
Q1 2024 Apr 18, 2024	BUY	$1.75 - $2.95 $1.82 Million - $3.07 Million	1,039,292 New	1,039,292 $2.68 Million
Q4 2022 Jan 24, 2023	BUY	$0.58 - $1.2 $726,699 - $1.5 Million	1,252,930 Added 108.25%	2,410,414 $0
Q3 2022 Oct 17, 2022	SELL	$0.66 - $2.32 $6.35 Million - $22.3 Million	-9,624,137 Reduced 89.26%	1,157,484 $760,000
Q2 2022 Jul 11, 2022	BUY	$1.57 - $3.33 $867,922 - $1.84 Million	552,817 Added 5.4%	10,781,621 $19.9 Million
Q1 2022 Apr 19, 2022	BUY	$2.76 - $4.64 $2.78 Million - $4.67 Million	1,006,389 Added 10.91%	10,228,804 $32.9 Million
Q4 2021 Jan 28, 2022	SELL	$4.09 - $7.16 $2.5 Million - $4.37 Million	-610,263 Reduced 6.21%	9,222,415 $39.7 Million
Q3 2021 Nov 12, 2021	SELL	$5.8 - $8.02 $12.4 Million - $17.2 Million	-2,142,929 Reduced 17.89%	9,832,678 $58.7 Million
Q2 2021 Aug 05, 2021	SELL	$6.87 - $9.16 $16.8 Million - $22.4 Million	-2,446,755 Reduced 16.97%	11,975,607 $99.2 Million
Q1 2021 May 13, 2021	SELL	$7.67 - $13.77 $20.4 Million - $36.6 Million	-2,660,944 Reduced 15.58%	14,422,362 $124 Million
Q4 2020 Feb 12, 2021	SELL	$12.07 - $17.95 $7.11 Million - $10.6 Million	-588,922 Reduced 3.33%	17,083,306 $207 Million
Q3 2020 Oct 30, 2020	BUY	$14.16 - $19.45 $50.6 Million - $69.5 Million	3,573,805 Added 25.35%	17,672,228 $287 Million
Q2 2020 Aug 11, 2020	BUY	$6.97 - $17.12 $26.3 Million - $64.6 Million	3,772,063 Added 36.53%	14,098,423 $212 Million
Q1 2020 May 14, 2020	BUY	$5.79 - $11.83 $7.82 Million - $16 Million	1,351,050 Added 15.05%	10,326,360 $75 Million
Q4 2019 Jan 31, 2020	BUY	$3.9 - $6.16 $1.11 Million - $1.75 Million	283,993 Added 3.27%	8,975,310 $53.5 Million
Q3 2019 Nov 12, 2019	BUY	$3.01 - $4.49 $585,974 - $874,095	194,676 Added 2.29%	8,691,317 $36.8 Million
Q2 2019 Jul 30, 2019	BUY	$2.8 - $4.14 $747,840 - $1.11 Million	267,086 Added 3.25%	8,496,641 $32.6 Million
Q1 2019 May 13, 2019	BUY	$2.35 - $4.19 $2.64 Million - $4.71 Million	1,123,597 Added 15.81%	8,229,555 $34.1 Million
Q4 2018 Feb 01, 2019	BUY	$2.17 - $3.8 $436,801 - $764,905	201,291 Added 2.92%	7,105,958 $15.4 Million
Q3 2018 Nov 07, 2018	BUY	$3.0 - $4.05 $4.6 Million - $6.2 Million	1,531,793 Added 28.51%	6,904,667 $26.6 Million
Q2 2018 Aug 07, 2018	BUY	$3.15 - $4.7 $4.34 Million - $6.48 Million	1,379,123 Added 34.53%	5,372,874 $17.7 Million
Q1 2018 May 14, 2018	BUY	$2.5 - $4.45 $4.35 Million - $7.74 Million	1,740,335 Added 77.23%	3,993,751 $17.8 Million
Q4 2017 Feb 12, 2018	BUY	$2.35 - $4.0 $2.59 Million - $4.41 Million	1,103,384 Added 95.94%	2,253,416 $5.63 Million
Q3 2017 Nov 09, 2017	BUY	$2.75 - $3.95 $1.62 Million - $2.33 Million	589,929 Added 105.33%	1,150,032 $4.37 Million
Q2 2017 Aug 11, 2017	BUY	N/A	285,653 Added 104.08%	560,103 $2.13 Million
Q1 2017 May 15, 2017	BUY	N/A	53,600 Added 24.27%	274,450 $1.18 Million
Q4 2016 Feb 13, 2017	BUY	N/A	220,850	220,850 $1.13 Million

Others Institutions Holding CGEN

# of Institutions

Shares Held

13.3M

Call Options Held

191K

Put Options Held

135K

View Full List

About COMPUGEN LTD

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $142M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

More about CGEN

Track Cathie Wood's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.

Account